TipRanks
Go Ultimate55% OFF

Hang Lung Group (0010) AI Stock Analysis

HK:0010

Hang Lung Group

(HKEX:0010)

Select Model
Rating:61Neutral
Price Target:HKD 12.50▲(2.97% Upside)
Action:reiterated
Date:08/04/26

Hang Lung Group's overall score of 61 reflects a stable but growth-challenged financial profile, mixed technical signals, and an attractive valuation. The company's strong balance sheet and cash flows provide a solid foundation, while the high dividend yield and moderate P/E offer value. However, stagnant revenue, low return on equity, and office segment headwinds limit upside potential. The recent earnings call reinforced a cautiously optimistic outlook, with Westlake 66 and retail momentum as key positives.

Positive Factors
Leasing and retail momentumGrowth in the core leasing business supports recurring earnings and demonstrates continued demand across the property portfolio. Positive mall sales, operating profit growth, and retail activity can reinforce occupancy, tenant retention, and the company’s long-term asset income base.
Negative Factors
Mainland office weaknessWeak Mainland office revenue presents a structural pressure on rental income and portfolio margins rather than a purely temporary earnings fluctuation. Competition and tenant incentives can make occupancy and pricing harder to defend, limiting profitability from these assets.

Hang Lung Group (0010) vs. iShares MSCI Hong Kong ETF (EWH)

-20%-15%-10%-5%0%5%10%15%20%HK:0010-14.18%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 2.11B
Dividend Yield
7.04%
Average Volume (3M)
824.03K
Price to Earnings (P/E)
11.7
Beta (1Y)
0.74
Revenue Growth
9.19%
EPS Growth
-0.21%
Country
Hong Kong
Employees
4,595
Sector
Real Estate
Sector Strength
65
Industry
Real Estate - Development

Hang Lung Group Business Overview & Revenue Model

Company Description

Hang Lung Group Limited, established in 1960 and based in Central, Hong Kong, functions as an investment holding company with a primary focus on real estate development across Hong Kong and mainland China. Its operations are divided into two main div...

How the Company Makes Money

Hang Lung Group makes money primarily through its property-related activities. Key revenue and earnings sources include: (1) Property investment income: recurring rental revenue generated from leasing space in its investment properties (e.g., retail,...

Hang Lung Group Earnings Call Summary

Earnings Call Date:Jul 30, 2026(Q2-2026)|% Change Since:-11.37%|Next Earnings Date:Jan 27, 2027
Earnings Call SentimentPositive

The call presented a balanced but predominantly constructive picture: recurring leasing and retail operations showed healthy momentum (leasing revenue +5%, Mainland mall sales and customer metrics strong, membership growth robust), balance sheet metrics improved (net gearing down, cost of borrowing lower) and Westlake 66 and other developments delivered promising early results. Offsetting these positives were one-off accounting provisions (notably a HK$124m Wuhan SA provision) that depressed headline results, notable softness in Mainland office revenue (-12%) and temporary margin pressure from new openings and lower capitalization. Management emphasised cautious optimism, prudent accounting and a focus on quality leasing and customer engagement, with dividend resumption and ESG progress as supporting signals. Net effect: more positives than negatives but with clear near-term headwinds in offices and some non-cash provisioning risks.

Positive Updates

Core leasing revenue growth
Leasing revenue increased by 5% with operating profit up 4%; core leasing business remains the main earnings driver and contributed the majority of recurring profit.

Negative Updates

One-off provision in Wuhan serviced apartment
A non-cash provision of approximately HK$124 million was taken for the Wuhan serviced-apartment (DP/SA) project, which materially skewed headline results and contributed to a reported negative 'optics' (management cited an apparent ~10% headline decline driven by this item).

Company Guidance

Management's guidance was cautiously constructive: they expect Mainland tenant sales to remain positive into H2 (management cited H1 retail trends of Q1 +24%, Q2 +9%, H1 about +6% and guided H2 to be “high single‑digit”), target Westlake 66 mall to break even by Q4 2026 with mall metrics already strong (May Golden Week avg ~120,000 daily footfall; stabilized 40k–50k; end‑June occupancy 89% with 98% commitment; 250 stores, ~100 first‑to‑market) and expect Westlake office occupancy to reach ~70% by end‑2027; key openings include Curio Wuxi (~Sept 2026), Mandarin Oriental (Q1 2027) and Kimpton Xujiahui (H2 2027), and Phase‑2 will expand GFA to ~150,000 sqm. On finances they flagged continued strength and flexibility: net gearing ~31.6%, average borrowing cost ~3.7%, ~50% of debt RMB‑denominated, average debt maturity ~3 years, ~HK$18bn unused facilities, 69% of debt maturing in >2 years, and finance‑cost capitalization expected to fall to ~30% for 2026. The Board resumed a cash dividend (no scrip this round), intends a progressive approach and signaled limited near‑term risk of a cut given current payout levels and balance‑sheet buffers.

Hang Lung Group Financial Statement Overview

Summary

Hang Lung Group maintains solid financials with strong operating margins (64.2%) and robust cash flow (HKD 4.3B operating cash flow). The balance sheet is conservative (debt/equity 0.56) but return on equity is low (1.39%). Revenue growth is stagnant (-1.8% in 2025) and net profit margin has narrowed to 13.2%. Overall, the company is stable but faces growth and profitability challenges.

Income Statement

55Neutral

Balance Sheet

50Neutral

Cash Flow

63Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.56B10.42B11.76B11.01B10.94B10.93B
Gross Profit6.69B6.69B6.83B7.92B7.68B7.82B
EBITDA5.94B6.31B5.21B7.20B7.08B7.26B
Net Income1.42B1.37B1.61B2.81B2.72B2.59B
Balance Sheet
Total Assets241.72B236.23B234.97B231.45B226.54B238.03B
Cash, Cash Equivalents and Short-Term Investments7.03B6.79B10.82B6.34B5.79B9.14B
Total Debt55.90B55.37B58.06B50.97B46.25B46.22B
Total Liabilities82.39B80.97B82.28B76.54B71.33B73.54B
Stockholders Equity102.30B98.88B95.78B94.36B92.82B95.84B
Cash Flow
Free Cash Flow1.02B4.02B5.04B3.91B378.00M-1.14B
Operating Cash Flow1.27B4.32B5.21B4.02B3.10B1.74B
Investing Cash Flow257.00M-2.31B-3.07B-2.85B-3.20B-1.44B
Financing Cash Flow1.95B-6.13B2.38B-566.00M-4.25B1.82B

Hang Lung Group Technical Analysis

Technical Analysis SentimentNeutral
Last Price12.14

Price Trends

50DMA12.29Negative
100DMA12.68Negative
200DMA13.96Negative

Market Momentum

MACD-0.06Negative
RSI51.22Neutral
STOCH59.74Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0010, the sentiment is Neutral. The current price of 12.14 is above the 20-day moving average (MA) of 12.11, below the 50-day MA of 12.29, and below the 200-day MA of 13.96, indicating a neutral trend. The MACD of -0.06 indicates Negative momentum. The RSI at 51.22 is Neutral, neither overbought nor oversold. The STOCH value of 59.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0010.

Hang Lung Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

HK:0010 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
HK:0010HK:001061NeutralHKD 16.63B11.741.41%7.04%9.19%-0.21%
HK:0041HK:004158NeutralHKD 10.32B-38.22-0.52%7.78%74.94%84.97%
HK:0012HK:001252NeutralHKD 135.75B20.322.11%4.49%45.52%13.35%
HK:0978HK:097842NeutralHKD 1.16B-0.45-39.42%―25.82%-27.10%
HK:3377HK:337740UnderperformHKD 356.62M-0.03239.84%―-4.40%-61.12%
HK:0017HK:001737UnderperformHKD 12.71B-0.65-16.35%―9.77%-72.68%

* Real Estate Sector Average

Performance Comparison

-50%0%50%HK:0010HK:0041HK:0012HK:0017HK:3377HK:0978Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:0010 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0010Hang Lung Group 12.21-1.93-13.66%
HK:0041Great Eagle Holdings 13.76-0.03-0.21%
HK:0012Henderson Land Development Co 28.041.596.03%
HK:0017New World Development Co. Ltd.5.05-2.36-31.85%
HK:3377Sino-Ocean Group Holding 0.03-0.09-76.27%
HK:0978China Merchants Land Limited0.24-0.06-19.66%

Hang Lung Group Corporate Events

Hang Lung Group Sets New Board and Committee Structure from October 2026

Sep 30, 2026

Hang Lung Group Limited has announced an updated composition of its board of directors, effective October 1, 2026, confirming Adriel Chan as chair, Leo Tak Lun Tsoi as chief executive officer, and Kenneth Ka Kui Chiu as chief financial officer among...

Hang Lung Group Sets Out Board and Committee Structure

Sep 7, 2026

Hang Lung Group Limited has announced the current composition of its board of directors, led by Chair Adriel Chan and Chief Executive Officer Weber Wai Pak Lo, with Leo Tak Lun Tsoi named Chief Executive Officer Designate and Kenneth Ka Kui Chiu serv...

Hang Lung Names Veteran Consumer Executive Leo Tsoi as New CEO

Aug 7, 2026

Hang Lung Group and Hang Lung Properties have appointed veteran consumer and retail executive Leo Tsoi as Executive Director and Chief Executive Officer Designate, effective 7 September 2026, with full transition to CEO on 1 October 2026. The move br...

Hang Lung Group Declares HKD 0.21 Interim Dividend for First Half of 2026

Jul 31, 2026

Hang Lung Group Limited has declared an interim ordinary cash dividend of HKD 0.21 per share for the six months ended 30 June 2026, payable in Hong Kong dollars. The announcement underscores the company’s continued commitment to returning cash...

Hang Lung Group Sets September CEO Transition With Weber Lo Moving to Advisory Role

Jul 31, 2026

Hang Lung Group and Hang Lung Properties have announced a planned leadership transition, appointing a new Chief Executive Officer Designate and Executive Director who will join the group on September 7, 2026 and assume the CEO role from October 1, 20...

Hang Lung Group Strengthens Governance With New Committee Appointment

Jul 31, 2026

Hang Lung Group Limited has appointed its Chair and Executive Director, Adriel Chan, as a member of the company’s Nomination and Remuneration Committee with immediate effect, adding to his existing role on the equivalent committee of its listed...

Hang Lung Group Clarifies Board and Committee Structure

Jul 31, 2026

Hang Lung Group Limited has updated its board composition and delineated the roles and functions of its directors, naming Adriel Chan as chair, Weber Wai Pak Lo as chief executive officer, and Kenneth Ka Kui Chiu as chief financial officer. The board...

Hang Lung Group Releases 2026 Interim Results Disclosure

Jul 31, 2026

Hang Lung Group Limited has released its 2026 interim results, providing investors with an update on the company’s performance for the first half of the year. The announcement includes financial highlights, a review of operations, consolidated...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 04, 2026